US Stock MarketDetailed Quotes

RPHM Reneo Pharmaceuticals

Watchlist
  • 1.460
  • -0.040-2.67%
Close Jul 10 16:00 ET
  • 1.460
  • 0.0000.00%
Post 16:00 ET
48.79MMarket Cap-672P/E (TTM)

Reneo Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-40.68%9.56M
54.24%83.05M
71.72%25.01M
50.92%20.89M
69.25%21.04M
23.88%16.12M
35.24%53.85M
37.07%14.56M
8.53%13.84M
34.71%12.43M
Selling and administrative expenses
-9.94%4.62M
63.79%26.44M
76.03%7.4M
86.21%7.27M
54.43%6.64M
37.33%5.13M
38.58%16.14M
19.32%4.21M
13.63%3.9M
45.78%4.3M
-General and administrative expense
-9.94%4.62M
63.79%26.44M
76.03%7.4M
86.21%7.27M
54.43%6.64M
37.33%5.13M
38.58%16.14M
19.32%4.21M
13.63%3.9M
45.78%4.3M
Research and development costs
-55.04%4.94M
50.15%56.61M
69.97%17.6M
37.07%13.62M
77.08%14.4M
18.46%10.99M
33.85%37.71M
45.87%10.36M
6.65%9.94M
29.51%8.13M
Operating profit
40.68%-9.56M
-54.24%-83.05M
-71.72%-25.01M
-50.92%-20.89M
-69.25%-21.04M
-23.88%-16.12M
-35.24%-53.85M
-37.07%-14.56M
-8.53%-13.84M
-34.71%-12.43M
Net non-operating interest income expense
Other net income (expense)
12.01%1.14M
199.26%5.67M
50.94%1.45M
103.12%1.69M
1,167.23%1.51M
4,938.10%1.02M
3,843.75%1.89M
5,558.82%962K
4,800.00%833K
891.67%119K
Other non- operating income (expenses)
12.01%1.14M
199.26%5.67M
50.94%1.45M
103.12%1.69M
1,167.23%1.51M
4,938.10%1.02M
3,843.75%1.89M
5,558.82%962K
4,800.00%833K
891.67%119K
Income before tax
44.22%-8.43M
-48.95%-77.39M
-73.19%-23.55M
-47.58%-19.2M
-58.63%-19.53M
-15.89%-15.11M
-30.64%-51.96M
-28.22%-13.6M
-2.14%-13.01M
-33.59%-12.31M
Income tax
Net income
44.22%-8.43M
-48.95%-77.39M
-73.19%-23.55M
-47.58%-19.2M
-58.63%-19.53M
-15.89%-15.11M
-30.64%-51.96M
-28.22%-13.6M
-2.14%-13.01M
-33.59%-12.31M
Net income continuous Operations
44.22%-8.43M
-48.95%-77.39M
-73.19%-23.55M
-47.58%-19.2M
-58.63%-19.53M
-15.89%-15.11M
-30.64%-51.96M
-28.22%-13.6M
-2.14%-13.01M
-33.59%-12.31M
Minority interest income
Net income attributable to the parent company
44.22%-8.43M
-48.95%-77.39M
-73.19%-23.55M
-47.58%-19.2M
-58.63%-19.53M
-15.89%-15.11M
-30.64%-51.96M
-28.22%-13.6M
-2.14%-13.01M
-33.59%-12.31M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
44.22%-8.43M
-48.95%-77.39M
-73.19%-23.55M
-47.58%-19.2M
-58.63%-19.53M
-15.89%-15.11M
-30.64%-51.96M
-28.22%-13.6M
-2.14%-13.01M
-33.59%-12.31M
Basic earnings per share
58.33%-0.25
-18.87%-2.52
-26.79%-0.71
-7.55%-0.57
-30.00%-0.65
-13.21%-0.6
3.20%-2.12
-30.23%-0.56
-1.92%-0.53
-16.28%-0.5
Diluted earnings per share
58.33%-0.25
-18.87%-2.52
-26.79%-0.71
-7.55%-0.57
-30.00%-0.65
-13.21%-0.6
3.20%-2.12
-30.23%-0.56
-1.92%-0.53
-16.28%-0.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -40.68%9.56M54.24%83.05M71.72%25.01M50.92%20.89M69.25%21.04M23.88%16.12M35.24%53.85M37.07%14.56M8.53%13.84M34.71%12.43M
Selling and administrative expenses -9.94%4.62M63.79%26.44M76.03%7.4M86.21%7.27M54.43%6.64M37.33%5.13M38.58%16.14M19.32%4.21M13.63%3.9M45.78%4.3M
-General and administrative expense -9.94%4.62M63.79%26.44M76.03%7.4M86.21%7.27M54.43%6.64M37.33%5.13M38.58%16.14M19.32%4.21M13.63%3.9M45.78%4.3M
Research and development costs -55.04%4.94M50.15%56.61M69.97%17.6M37.07%13.62M77.08%14.4M18.46%10.99M33.85%37.71M45.87%10.36M6.65%9.94M29.51%8.13M
Operating profit 40.68%-9.56M-54.24%-83.05M-71.72%-25.01M-50.92%-20.89M-69.25%-21.04M-23.88%-16.12M-35.24%-53.85M-37.07%-14.56M-8.53%-13.84M-34.71%-12.43M
Net non-operating interest income expense
Other net income (expense) 12.01%1.14M199.26%5.67M50.94%1.45M103.12%1.69M1,167.23%1.51M4,938.10%1.02M3,843.75%1.89M5,558.82%962K4,800.00%833K891.67%119K
Other non- operating income (expenses) 12.01%1.14M199.26%5.67M50.94%1.45M103.12%1.69M1,167.23%1.51M4,938.10%1.02M3,843.75%1.89M5,558.82%962K4,800.00%833K891.67%119K
Income before tax 44.22%-8.43M-48.95%-77.39M-73.19%-23.55M-47.58%-19.2M-58.63%-19.53M-15.89%-15.11M-30.64%-51.96M-28.22%-13.6M-2.14%-13.01M-33.59%-12.31M
Income tax
Net income 44.22%-8.43M-48.95%-77.39M-73.19%-23.55M-47.58%-19.2M-58.63%-19.53M-15.89%-15.11M-30.64%-51.96M-28.22%-13.6M-2.14%-13.01M-33.59%-12.31M
Net income continuous Operations 44.22%-8.43M-48.95%-77.39M-73.19%-23.55M-47.58%-19.2M-58.63%-19.53M-15.89%-15.11M-30.64%-51.96M-28.22%-13.6M-2.14%-13.01M-33.59%-12.31M
Minority interest income
Net income attributable to the parent company 44.22%-8.43M-48.95%-77.39M-73.19%-23.55M-47.58%-19.2M-58.63%-19.53M-15.89%-15.11M-30.64%-51.96M-28.22%-13.6M-2.14%-13.01M-33.59%-12.31M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 44.22%-8.43M-48.95%-77.39M-73.19%-23.55M-47.58%-19.2M-58.63%-19.53M-15.89%-15.11M-30.64%-51.96M-28.22%-13.6M-2.14%-13.01M-33.59%-12.31M
Basic earnings per share 58.33%-0.25-18.87%-2.52-26.79%-0.71-7.55%-0.57-30.00%-0.65-13.21%-0.63.20%-2.12-30.23%-0.56-1.92%-0.53-16.28%-0.5
Diluted earnings per share 58.33%-0.25-18.87%-2.52-26.79%-0.71-7.55%-0.57-30.00%-0.65-13.21%-0.63.20%-2.12-30.23%-0.56-1.92%-0.53-16.28%-0.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg